Previously Treated Childhood Rhabdomyosarcoma Completed Phase 1 Trials for Erlotinib (DB00530)

IndicationStatusPhase
DBCOND0028747 (Previously Treated Childhood Rhabdomyosarcoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00077454Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsTreatment